Favorable outcome of rivaroxaban-associated intracerebral hemorrhage reversed by 4-factor prothrombin complex concentrate: impact on thrombin generation

A & A case reports

Volumn 4, Issue 11, 2015, Pages 151-154

  Kauffmann, Sophie ^a   Chabanne, Russell ^a   Coste, Aurélien ^a   Longeras, François ^a   Sinegre, Thomas ^a   Schmidt, Jeannot ^a   Samama, Charles Marc ^a   Constantin, Jean Michel ^a   Lebreton, Aurélien ^a  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10A INHIBITOR; PROTHROMBIN COMPLEX CONCENTRATES; RIVAROXABAN; THROMBIN;

AGED; BIOSYNTHESIS; BLOOD CLOTTING; BLOOD CLOTTING TEST; CASE REPORT; CEREBRAL HEMORRHAGE; CHEMICALLY INDUCED; DRUG EFFECTS; HEMATOMA, SUBDURAL; HUMAN; MALE;

AGED; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; CEREBRAL HEMORRHAGE; FACTOR XA INHIBITORS; HEMATOMA, SUBDURAL; HUMANS; MALE; RIVAROXABAN; THROMBIN;

EID: 84953342816     PISSN: None     EISSN: 23257237     Source Type: Journal    
DOI: 10.1213/XAA.0000000000000143     Document Type: Article

References (0)